Talking Therapy Equals Antidepressant Drugs For
Severely Depressed
Study finds it's also
cheaper in the short run
Talking therapy is equally if not more effective as
antidepressant drugs
at preventing the return of severe
depression over time, yet is cheaper than drugs in the short run.
A new study that says so-called
cognitive therapymay trump
medication for
severe
depression may strike many therapists as improbable.
Psychiatric practice guidelines state most people with
moderate or severe mood problems will need antidepressant drugs.
However, over the course of the 16-month study,
the risk of relapse was no higher, and perhaps even lower, for those who
received cognitive therapy than it was among patients taking antidepressants,
the researchers found. Although mood medication led to much faster improvements
in symptoms, that gap closed as the study progressed.
Antidepressants cost an average of about $350
more per patient than therapy alone -- $2,590 versus $2,250. However, the
researchers say that's because cognitive therapy was front-loaded, and over the
long term depression medication would be the cheaper alternative.
"If this were a new drug, people would be
getting enthusiastic about it," says Steven Hollon, a Vanderbilt
University psychologist and a co-author of the study. Hollon says that while a
single study would be unlikely to change practice guidelines, the new results
should help move the field forward.
The researchers presented their findings at at
the May 2002 meeting of the American Psychiatric Association in Philadelphia.
Cognitive therapy helps people with depression
cope with stresses that might buffet them in the future. It teaches them to
examine their thinking for whiffs of unreality, and asks them to test those
beliefs against real events.
Hollon and his colleagues followed 240 people
with severe depression for 16 months. The first four months focused on
resolving the acute mood problem, while the next year involved preserving the
gains for those who improved.
A third of the patients received cognitive
therapy, a third got the antidepressant Paxil (sold by GlaxoSmithKline, which
helped fund the study), and the rest were given placebo pills. People in the
drug and placebo groups also received help and encouragement taking their
medication, though neither they nor the therapists knew who was receiving what.
After the first eight weeks, the active drug
proved superior to either therapy or sham treatment at improving
symptoms of
depression on a standardized scale, the researchers found. However, by 16
weeks, 57 percent of people in both treatment groups showed significant
improvement. The rate of full recovery was somewhat higher in the
antidepressant drug group.
For the next 12 months, people who improved on
cognitive therapy stopped regular treatment, undergoing at most three more
sessions through the end of the study. Half the rest either stayed on Paxil or
were switched, with their consent, to placebo pills.
Yet, despite effectively suspending treatment,
only a quarter of those receiving cognitive therapy suffered at least a partial
relapse during the 12-month follow-up, compared with 40 percent of the patients
on Paxil. The third group fared much worse, with 81 percent relapsing.
Robert DeRubeis, a University of Pennsylvania
psychologist and study co-author, says the results show cognitive therapy has a
lasting effect while depression medication only helps as long as it's being
taken.
"It ought to make psychiatrists feel that
there are still additional ways to treat" severe depression beyond writing
prescriptions. In most states, psychiatrists, but not psychologists, can
prescribe medication.
Still, while the two therapies may be equally
effective, not all patients with depression are the same. In a related study,
Dr. Richard Shelton, a Vanderbilt University psychiatrist, analyzed the 240
patients to see if some were more likely to respond to treatment than others.
Shelton, who also presented his findings at the
psychiatry meeting, found people with
underlying
anxiety disorders did much better on medication than they did on cognitive
therapy. Meanwhile, patients with chronic depression or a history of
post-traumatic stress disorder were less likely to improve
with either treatment.
Shelton's group also found that patients with a
history of mood problems or chronic depression, and those whose
depression appeared early in
life, were most likely to suffer
relapses during the
year of follow-up.
A government panel has recommended that every
American adult be screened at the doctor's office for depression.
Clinical depression
affects between 5 percent and 9 percent of people over 18 in this
country.
Source: HealthScout News, May 23,
2002
top ~
next ~
send page to a
friend
HealthyPlace.com
Depression Center Links
home ~ site map ~
causes ~ types ~
people ~
living with
treatments ~ self-help ~ support ~ suicide ~ related
issues
|